Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?

Diabetes Technology and Therapeutics

Volumn 14, Issue 5, 2012, Pages 389-397

  Shalitin, Shlomit ^a,b   Lahav Ritte, Tamar ^b   Lebenthal, Yael ^a   Devries, Liat ^a,b   Phillip, Moshe ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; ISOPHANE INSULIN; LONG ACTING INSULIN; SHORT ACTING INSULIN;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BLOOD GLUCOSE MONITORING; CHILD; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFECT; DRUG SAFETY; EARLY INTERVENTION; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; FOLLOW UP; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; TREATMENT DURATION; TREATMENT INDICATION;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC KETOACIDOSIS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INFUSIONS, SUBCUTANEOUS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; ISRAEL; MALE; RETROSPECTIVE STUDIES; TIME FACTORS; YOUNG ADULT;

EID: 84860579932     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2011.0267     Document Type: Conference Paper

References (27)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977-986.
2. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: Diabetes Control and Complications Trial Research Group. J Pediatr 1994; 125:177-188.
3. White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV; Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Research Group: Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001;139:804-812.
4. Strudwick SK, Carne C, Gardiner J, Foster JK, Davis EA, Jones TW: Cognitive functioning in children with early onset type 1 diabetes and severe hypoglycemia. J Pediatr 2005; 147:680-685.
5. Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Intervention and Complications Research Group: Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: the Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA 2003;290:2159-2167.
6. Nabhan ZM, Rardin L, Meier J, Eugster EA, DiMeglio LA: Predictors of glycemic control on insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Res Clin Pract 2006;74:217-221.
7. Cukierman-Yaffe T, Konvalina N, Cohen O: Key elements for successful intensive insulin pump therapy in individuals with type 1 diabetes. Diabetes Res Clin Pract 2001;92:69-73.
8. Plotnick LP, Clark LM, Brancati T, Erlinger T: Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003;4:1142-1146.
9. Shalitin S, Gil M, Nimri R, de Vries L, GaVan MY, Phillip M: Predictors of glycemic control in patients with type 1 diabetes switched to insulin pump therapy. Diabet Med 2010; 27:339-347.
10. Rewers M, Pihoker C, Donaghue K, Hanas R, Swift P, Klingensmith GJ: Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatr Diabetes 2007;8:408-418.
11. Battelino T, Danne T, Kaufman F, Phillip M, Rodriguez H: Use of insulin pump therapy in the pediatric age-group. Diabetes Care 2007;30:1653-1659.
12. Dixon WJ: BMDP Statistical Software. Berkeley, CA: University of California Press, 1993.
13. Pinhas-Hamiel O, Tzadok M, Hirsh G, Boyko V, Graph- Barel C, Lerner-Geva L, Reichman B: The impact of baseline hemoglobin A1c levels prior to initiation of pump therapy on long-term metabolic control. Diabetes Technol Ther 2010;12:567-573.
14. de Beaufort CE, Houtzagers CM, Bruining GJ, Aarsen RS, den Boer NC, Grose WF, Van Strik R, de Visser JJ: Continuous subcutaneous insulin infusion (CSII) versus conventional injection therapy in newly diagnosed diabetic children: two-year follow-up of a randomized, prospective trial. Diabet Med 1989;6:766-771.
15. Ramchandani N, Ten S, Anhalt H, Sinha S, Ching J, Finkelstein A, Maclaren NK: Insulin pump therapy from the time of diagnosis of type 1 diabetes. Diabetes Technol Ther 2006;8:663-670.
16. Thrailkill KM, Moreau CS, Swearingen C, Rettiganti M, Edwards K, Morales AE, Kemp SF, Frindik JP, Fowlkes JL: Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic b-cell function in type 1 diabetes. Diabetes Technol Ther 2011;13:1023-1030.
17. Monami M, Lamanna C, Marchionni N, Mannucci E: Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis. Acta Diabetol 2010;47(Suppl 1):77-81.
18. Berghaeuser MA, Kapellen T, Heidtmann B, Haberland H, Klinkert C, Holl RW; German Working Group for Insulin Pump Treatment in Paediatric Patients: Continuous subcutaneous insulin infusion in toddlers starting at diagnosis of type 1 diabetes mellitus. A multicenter analysis of 104 patients from 63 centres in Germany and Austria. Pediatr Diabetes 2008;9:590-595.
19. Sulmont V, Souchon PF, Gouillard-Darnaud C, Fartura A, Salmon-Musial AS, Lambrecht E, Mauran P, Abely M: Metabolic control in children with diabetes mellitus who are younger than 6 years at diagnosis: continuous subcutaneous insulin infusion as a first line treatment? J Pediatr 2010;157:103-107.
20. Insabella G, Grey M, Knafl G, Tamborlane W: The transition to young adulthood in youth with type 1 diabetes on intensive treatment. Pediatr Diabetes 2007;8:228-234.
21. Altobelli E, Valenti M, Verrotti A, Masedu F, Tiberti S, Chiarelli F, Di Orio F: Family and disease management in young type 1 diabetic patients. Acta Diabetol 2000; 37:173-178.
22. Haller MJ, Stalvey MS, Silverstein JH: Predictors of control of diabetes: monitoring may be the key. J Pediatr 2004;144:660-661.
23. Levine BS, Anderson BJ, Butler DA, Antisdel JE, Brackett J, Laffel LMB: Predictors of glycemic control and short-term adverse outcomes in youth with type 1 diabetes. J Pediatr 2001;139:197-203.
24. Shehadeh N, Battelino T, Galatzer A, Naveh T, Hadash A, de Vries L, Phillip M: Insulin pump therapy for 1-6 year old children with type 1 diabetes. Isr Med Assoc J 2004;6:284-286.
25. Boland EA, Grey M, Oesterele A, Fredrickson L, Tamborlane WV: Continuous subcutaneous insulin infusion: a new way to lower risk of severe hypoglycemia, improve metabolic control, and enhance coping in adolescents with type 1 diabetes. Diabetes Care 1999;22:1779-1784.
26. Sulli N, Shashaj B: Continuous subcutaneous insulin infusion in children and adolescents with diabetes mellitus: decreased HbA1c with low risk of hypoglycemia. J Pediatr Endocrinol Metab 2003;16:393-399.
27. Kapellen TM, Heidtmann B, Bachmann J, Ziegler R, Grabert M, Holl RW: Indications for insulin pump therapy in different age groups-an analysis of 1567 children and adolescents. Diabet Med 2007;24:836-842.